Cobimetinib
Cobimetinib (pronounced as koh-bi-ME-ti-nib) is a type of cancer medication that interferes with the growth and spread of cancer cells in the body. It is used in combination with another medication called vemurafenib to treat a certain type of melanoma (skin cancer) that has spread to other parts of the body or cannot be removed by surgery.
Etymology
The name "Cobimetinib" is derived from the chemical structure of the drug. The prefix "Cobi-" is an abbreviation of the chemical name, while "-metinib" is a common suffix for drugs that inhibit kinase enzymes.
Usage
Cobimetinib is used in combination with vemurafenib to treat melanoma that has spread or cannot be removed by surgery. It works by blocking the action of an abnormal protein that signals cancer cells to multiply. This helps slow or stop the spread of cancer cells.
Side Effects
Common side effects of cobimetinib include diarrhea, rash, nausea, fever, and photosensitivity. Serious side effects can include liver problems, skin problems, eye problems, and heart problems.
Related Terms
See Also
External links
- Medical encyclopedia article on Cobimetinib
- Wikipedia's article - Cobimetinib
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski